After synthesis, DNA nanocages can be loaded with commercially available medicines for therapeutics ranging from cancer to neurodegenerative diseases. These vehicles can then be used for passive or active targeting and subsequent delivery in vivo, reducing side effects and increasing the proportion of drug which makes it to the intended delivery site.
